Lilly taps Shaquille O’Neal to spotlight sleep apnea
“Moderate-to-severe obstructive sleep apnea is more than just snoring – it’s a serious condition and it deserves serious attention,” O’Neal said.
Eli Lilly
Lilly to buy Adverum Biotechnologies
The acquisition strengthens Lilly’s genetic medicine pipeline and expands its footprint in ophthalmology.
Lilly’s oral GLP-1 drug nears global filing
Lilly’s oral GLP-1 pill helped patients lose 22 pounds and lower A1C in a Phase 3 trial, with global filings planned this year.
Lilly to expand collaboration with Purdue University
Will include a planned investment up to a $250 million to accelerate pharmaceutical innovation.
LillyDirect platform expands to improve access to Alzheimer's care
Eli Lilly and Company enhances digital healthcare offerings to address delays in diagnosis and treatment.